Cargando…
Heparin-binding epidermal growth factor-like growth factor and hepatocyte growth factor inhibit cholestatic liver injury in mice through different mechanisms
In contrast to hepatocyte growth factor (HGF), the therapeutic potential and pathophysiologic roles of heparin-binding epidermal growth factor-like growth factor (HB-EGF) in liver diseases remain relatively unknown. To address the lack of effective pharmacologic treatments for cholestatic liver inju...
Autores principales: | Sakamoto, Kouichi, Khai, Ngin Cin, Wang, Yuqing, Irie, Rie, Takamatsu, Hideo, Matsufuji, Hiroshi, Kosai, Ken-Ichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117744/ https://www.ncbi.nlm.nih.gov/pubmed/27779646 http://dx.doi.org/10.3892/ijmm.2016.2784 |
Ejemplares similares
-
Intramuscular injection of adenoviral hepatocyte growth factor at a distal site ameliorates dextran sodium sulfate-induced colitis in mice
por: YUGE, KENTARO, et al.
Publicado: (2014) -
A heparin-modified thermoresponsive surface with heparin-binding epidermal growth factor-like growth factor for maintaining hepatic functions in vitro and harvesting hepatocyte sheets
por: Arisaka, Yoshinori, et al.
Publicado: (2016) -
Epidermal growth factor signaling protects from cholestatic liver injury and fibrosis
por: Svinka, Jasmin, et al.
Publicado: (2016) -
Heparin-binding epidermal growth factor-like growth factor suppresses experimental liver fibrosis in mice
por: Huang, Guangcun, et al.
Publicado: (2012) -
Fibrogenic Effects of Heparin-Binding Epidermal Growth Factor-like Growth Factor: Myeloid or Epithelial Origin?
por: Martin, James G., et al.
Publicado: (2022)